Capital International Investors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,095,069
Closed -$36.3M 434
2022
Q3
$36.3M Sell
4,095,069
-3,670,870
-47% -$46.2M 0.01% 350
2022
Q2
$98.2M Sell
7,765,939
-1,339,164
-15% -$17.1M 0.03% 295
2022
Q1
$174M Buy
9,105,103
+50,212
+0.6% +$1.28M 0.04% 263
2021
Q4
$318M Buy
9,054,891
+128,422
+1% +$4.17M 0.07% 223
2021
Q3
$326M Buy
8,926,469
+2,066,652
+30% +$81.3M 0.07% 211
2021
Q2
$262M Buy
6,859,817
+1,159,253
+20% +$33.5M 0.06% 226
2021
Q1
$161M Buy
5,700,564
+1,127,862
+25% +$36M 0.04% 248
2020
Q4
$146M Buy
4,572,702
+65,260
+1% +$2.01M 0.04% 256
2020
Q3
$145M Buy
4,507,442
+339,879
+8% +$10.6M 0.04% 245
2020
Q2
$115M Buy
4,167,563
+1,122,483
+37% +$24.3M 0.04% 245
2020
Q1
$54.4M Buy
3,045,080
+1,126,259
+59% +$27.2M 0.02% 253
2019
Q4
$48.1M Buy
1,918,821
+662,934
+53% +$14.5M 0.02% 270
2019
Q3
$22.4M Buy
1,255,887
+249,180
+25% +$5.19M 0.01% 317
2019
Q2
$22.1M Buy
1,006,707
+418,219
+71% +$11.9M 0.01% 326
2019
Q1
$235M Buy
+588,488
New +$14.7M 0.1% 171

Other funds holding HCM

Capital International Investors's HCM Position: Q4 2022 in Review

Capital International Investors sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 4,095,069 shares — an estimated $36.3M sold.

Capital International Investors first reported a position in HCM in Q1 2019 and held it in 15 quarters. The position peaked at $326M in Q3 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Capital International Investors reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Capital International Investors sold 4,095,069 HUTCHMED shares in Q4 2022, an estimated $36.3M.
  • Capital International Investors first reported a position in HUTCHMED in Q1 2019 and held it in 15 quarters.
  • Capital International Investors's HUTCHMED position peaked at $326M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Capital International Investors's 13F filing for Q4 2022, filed 14 Feb 2023.